We developed (Zn-Adenine)@Ab@lncRNA LEF1-AS1 nano-drug for RA treatment by modifying the Zn-Adenine metal organic framework with anti-CD305 antibody and loading LEF1-AS1. Here, LEF1 is linked to rheumatoid arthritis.